Newsroom category: Insulin Overpricing News

Mike Papantonio Unveils Explosive New Legal Thriller “The Middleman”

March 4, 2025

Renowned trial lawyer and best-selling author Mike Papantonio is pulling back the curtain on one of the pharmaceutical industry’s most shadowy players with the release of his latest legal thriller, The Middleman. The novel delivers a high-stakes drama of whistleblowers, murder, and legal warfare—ripped straight from today’s headlines. The Middleman is available now at major bookstores and online retailers, […]

Read More

JPML Centralizes Lawsuits Over Insulin Pricing Scheme

August 4, 2023

The nationally recognized mass tort law firm Levin Papantonio Rafferty (LPR) announces that the Judicial Panel on Multidistrict Litigation (JPML) today created a multidistrict litigation (MDL) for insulin price-fixing lawsuits. The JPML issued a Transfer Order to centralize lawsuits alleging that drug manufacturers and pharmacy benefit manufacturers (PBMs) engaged in an unfair and deceptive conspiracy […]

Read More